ImmunityBio, Inc. (IBRX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$4,047
Total Return
-59.53%
CAGR
-16.55%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +4.62% |
| Median | -3.86% |
| Best | +303.90% |
| Worst | -64.93% |
| % of Windows Positive | 43.0% |
1-Year (252 Trading Days)
| Average | +14.64% |
| Median | -28.86% |
| Best | +343.71% |
| Worst | -81.17% |
| % of Windows Positive | 32.8% |
3-Year (756 Trading Days)
| Average | +1.83% |
| Median | -46.56% |
| Best | +557.34% |
| Worst | -70.81% |
| % of Windows Positive | 19.4% |
Risk Metrics
| Maximum Drawdown | -92.93% |
| Average Drawdown | -72.58% |
| Drawdown Duration | 1254 Trading Days (Unrecovered) |
| Sortino Ratio | 0.65 |
| Calmar Ratio | -0.18 |
| CVaR (5%) | -13.01% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +262.63% (+2022.79% ann.) | +$26262.88 | $0.00 | $0.00 | $0.00 |
| 2025 | -22.66% | $2265.67 | $0.00 | $0.00 | $0.00 |
| 2024 | -49.00% | $4900.39 | $0.00 | $0.00 | $0.00 |
| 2023 | -0.99% | $98.66 | $0.00 | $0.00 | $0.00 |
| 2022 | -16.61% | $1661.18 | $0.00 | $0.00 | $0.00 |
| 2021 | -54.39% | $5438.85 | $0.00 | $0.00 | $0.00 |
| 2020 | +251.72% | +$25171.51 | $0.00 | $0.00 | $0.00 |
| 2019 | +226.73% | +$22672.68 | $0.00 | $0.00 | $0.00 |
| 2018 | -74.17% | $7416.51 | $0.00 | $0.00 | $0.00 |
| 2017 | -21.50% | $2150.34 | $0.00 | $0.00 | $0.00 |
| 2016 | -66.99% | $6699.37 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -49.97% (-80.24% ann.) | $4997.11 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | July 28, 2015 – February 19, 2020 | -82.48% | -31.72% | $8247.69 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -52.68% | -99.98% | $5268.43 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +172.15% | +400.74% | +$17214.63 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -10.13% | -9.63% | $1012.65 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -44.16% | -46.13% | $4415.95 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -36.52% | -21.74% | $3652.02 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +109.94% | +54.47% | +$10994.13 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.